Providence Therapeutics Company

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.

Investors

Connections from

Total Funding: $3 476 087
Headquarters: Toronto, Ontario, Canada
Last Funding Type: Venture - Series Unknown
Last Funding Date: 2020-07-23
Founded Date: 2015-01-01
Industry: Women Cancer Treatment
Register and Claim Ownership